Want to see HK:6660 full AI Analyst Report?
AIM Vaccine Co., Ltd. Class H (6660) Ratios
AIM Vaccine Co., Ltd. Class H Ratios
HK:6660's free cash flow for Q2 2026 was $-73.79M. For the 2026 fiscal year, HK:6660's free cash flow was decreased by $-25.70M and operating cash flow was $-48.09M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.66 | 0.77 | 0.95 | 1.13 | 1.50 |
| Quick Ratio | 0.55 | 0.62 | 0.76 | 0.91 | 1.27 |
| Cash Ratio | 0.12 | 0.16 | 0.22 | 0.28 | 0.41 |
| Solvency Ratio | -0.14 | -0.04 | -0.33 | -0.05 | -0.23 |
| Operating Cash Flow Ratio | 0.02 | 0.03 | -0.06 | -0.05 | 0.06 |
| Short-Term Operating Cash Flow Coverage | 0.05 | 0.07 | -0.14 | -0.11 | 0.23 |
| Net Current Asset Value | $ -1.56B | $ -1.32B | $ -889.48M | $ -466.18M | $ -14.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.25 | 0.25 | 0.16 | 0.08 |
| Debt-to-Equity Ratio | 0.64 | 0.55 | 0.49 | 0.28 | 0.13 |
| Debt-to-Capital Ratio | 0.39 | 0.35 | 0.33 | 0.22 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.11 | 0.13 | 0.06 | 0.04 |
| Financial Leverage Ratio | 2.37 | 2.17 | 1.99 | 1.79 | 1.65 |
| Debt Service Coverage Ratio | -0.02 | -0.06 | -1.39 | -0.04 | -1.25 |
| Interest Coverage Ratio | -3.69 | -3.47 | -80.13 | -14.96 | -60.61 |
| Debt to Market Cap | 0.49 | 0.26 | 0.20 | 0.06 | 0.05 |
| Interest Debt Per Share | 1.48 | 1.58 | 1.52 | 1.38 | 0.69 |
| Net Debt to EBITDA | -27.96 | -13.63 | -0.59 | -3.15 | -0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.86% | 74.20% | -51.47% | 81.30% | 82.46% |
| EBIT Margin | -18.01% | -17.89% | -187.53% | -32.31% | -37.96% |
| EBITDA Margin | -4.29% | -7.69% | -172.81% | -19.15% | -28.77% |
| Operating Profit Margin | -18.01% | -16.41% | -295.78% | -30.40% | -41.32% |
| Pretax Profit Margin | -66.41% | -22.62% | -191.22% | -34.35% | -38.64% |
| Net Profit Margin | -58.51% | -21.57% | -109.56% | -25.28% | -44.12% |
| Continuous Operations Profit Margin | -62.76% | -21.67% | -164.24% | -18.24% | -43.05% |
| Net Income Per EBT | 88.12% | 95.36% | 57.30% | 73.61% | 114.19% |
| EBT Per EBIT | 368.77% | 137.84% | 64.65% | 112.97% | 93.52% |
| Return on Assets (ROA) | -10.32% | -3.79% | -17.92% | -3.60% | -8.58% |
| Return on Equity (ROE) | -24.47% | -8.24% | -35.71% | -6.44% | -14.16% |
| Return on Capital Employed (ROCE) | -6.02% | -4.99% | -75.37% | -5.80% | -9.98% |
| Return on Invested Capital (ROIC) | -4.16% | -3.59% | -51.25% | -2.67% | -9.37% |
| Return on Tangible Assets | -12.61% | -4.58% | -19.41% | -5.19% | -12.84% |
| Earnings Yield | -19.14% | -3.99% | -14.95% | -1.48% | -5.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.96 | 1.09 | 1.18 | 1.20 | 1.48 |
| Payables Turnover | 5.07 | 6.51 | 29.80 | 3.21 | 5.32 |
| Inventory Turnover | 1.17 | 0.72 | 3.53 | 0.47 | 0.75 |
| Fixed Asset Turnover | 0.36 | 0.37 | 0.34 | 0.35 | 0.52 |
| Asset Turnover | 0.18 | 0.18 | 0.16 | 0.14 | 0.19 |
| Working Capital Turnover Ratio | -1.32 | -3.13 | 13.20 | 2.32 | 1.50 |
| Cash Conversion Cycle | 619.69 | 789.44 | 400.15 | 969.60 | 665.54 |
| Days of Sales Outstanding | 378.84 | 336.14 | 308.93 | 303.94 | 247.26 |
| Days of Inventory Outstanding | 312.87 | 509.33 | 103.46 | 779.27 | 486.88 |
| Days of Payables Outstanding | 72.02 | 56.03 | 12.25 | 113.60 | 68.60 |
| Operating Cycle | 691.71 | 845.47 | 412.40 | 1083.20 | 734.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.06 | 0.08 | -0.14 | -0.11 | 0.10 |
| Free Cash Flow Per Share | -0.14 | -0.12 | -0.39 | -0.94 | -1.09 |
| Dividend Paid and CapEx Coverage Ratio | 0.28 | 0.42 | -0.55 | -0.13 | 0.08 |
| Capital Expenditure Coverage Ratio | 0.28 | 0.42 | -0.55 | -0.13 | 0.08 |
| Operating Cash Flow Coverage Ratio | 0.04 | 0.05 | -0.09 | -0.08 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.08 | -0.14 | -0.09 | 0.06 |
| Free Cash Flow Yield | -4.86% | -2.00% | -5.37% | -4.46% | -8.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.24 | -25.07 | -6.69 | -67.79 | -18.84 |
| Price-to-Sales (P/S) Ratio | 3.06 | 5.41 | 7.33 | 17.14 | 8.31 |
| Price-to-Book (P/B) Ratio | 1.28 | 2.07 | 2.39 | 4.37 | 2.67 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -20.59 | -49.98 | -18.63 | -22.41 | -12.45 |
| Price-to-Operating Cash Flow Ratio | 52.30 | 70.08 | -52.58 | -196.40 | 139.78 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 0.32 | -0.03 | 1.19 | 0.07 |
| Enterprise Value Multiple | -99.19 | -83.96 | -4.83 | -92.67 | -28.91 |
| Enterprise Value | 4.91B | 8.30B | 9.91B | 22.43B | 13.06B |
| EV to EBITDA | -99.19 | -83.96 | -4.83 | -92.67 | -28.91 |
| EV to Sales | 4.26 | 6.46 | 8.35 | 17.74 | 8.32 |
| EV to Free Cash Flow | -28.67 | -59.66 | -21.22 | -23.20 | -12.46 |
| EV to Operating Cash Flow | 72.83 | 83.66 | -59.91 | -203.32 | 139.82 |
| Tangible Book Value Per Share | 1.43 | 1.95 | 2.75 | 3.05 | 3.14 |
| Shareholders’ Equity Per Share | 2.26 | 2.79 | 3.01 | 4.81 | 5.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.04 | 0.14 | 0.47 | -0.11 |
| Revenue Per Share | 0.94 | 1.07 | 0.98 | 1.23 | 1.63 |
| Net Income Per Share | -0.55 | -0.23 | -1.07 | -0.31 | -0.72 |
| Tax Burden | 0.88 | 0.95 | 0.57 | 0.74 | 1.14 |
| Interest Burden | 3.69 | 1.26 | 1.02 | 1.06 | 1.02 |
| Research & Development to Revenue | 0.17 | 0.28 | 1.81 | 0.40 | 0.20 |
| SG&A to Revenue | 0.67 | 0.64 | 0.21 | 0.36 | 0.74 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.01 | 0.18 | 0.61 |
| Income Quality | -0.09 | -0.34 | 0.13 | 0.25 | -0.13 |
Currency in CNY